JP2012513982A5 - - Google Patents

Download PDF

Info

Publication number
JP2012513982A5
JP2012513982A5 JP2011543072A JP2011543072A JP2012513982A5 JP 2012513982 A5 JP2012513982 A5 JP 2012513982A5 JP 2011543072 A JP2011543072 A JP 2011543072A JP 2011543072 A JP2011543072 A JP 2011543072A JP 2012513982 A5 JP2012513982 A5 JP 2012513982A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
alkyl group
aromatic
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011543072A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012513982A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2009/071919 external-priority patent/WO2010076896A1/en
Publication of JP2012513982A publication Critical patent/JP2012513982A/ja
Publication of JP2012513982A5 publication Critical patent/JP2012513982A5/ja
Pending legal-status Critical Current

Links

JP2011543072A 2008-12-29 2009-12-28 癌の予防・治療剤 Pending JP2012513982A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20388708P 2008-12-29 2008-12-29
US61/203,887 2008-12-29
PCT/JP2009/071919 WO2010076896A1 (en) 2008-12-29 2009-12-28 Prophylactic/therapeutic agent for cancer

Publications (2)

Publication Number Publication Date
JP2012513982A JP2012513982A (ja) 2012-06-21
JP2012513982A5 true JP2012513982A5 (enExample) 2013-01-31

Family

ID=42025816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011543072A Pending JP2012513982A (ja) 2008-12-29 2009-12-28 癌の予防・治療剤

Country Status (26)

Country Link
US (1) US20110312898A1 (enExample)
EP (1) EP2379053A1 (enExample)
JP (1) JP2012513982A (enExample)
KR (1) KR20110111420A (enExample)
CN (1) CN102333520B (enExample)
AR (1) AR074918A1 (enExample)
AU (1) AU2009334235A1 (enExample)
BR (1) BRPI0923663A2 (enExample)
CA (1) CA2748517A1 (enExample)
CL (1) CL2011001519A1 (enExample)
CO (1) CO6382105A2 (enExample)
CR (1) CR20110374A (enExample)
DO (1) DOP2011000163A (enExample)
EA (1) EA019738B1 (enExample)
EC (1) ECSP11011166A (enExample)
GE (1) GEP20146001B (enExample)
IL (1) IL212913A0 (enExample)
MA (1) MA32935B1 (enExample)
MX (1) MX2011006170A (enExample)
NZ (1) NZ593381A (enExample)
PE (1) PE20110939A1 (enExample)
TN (1) TN2011000250A1 (enExample)
TW (1) TW201029660A (enExample)
UY (1) UY32367A (enExample)
WO (1) WO2010076896A1 (enExample)
ZA (1) ZA201103627B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8592379B2 (en) * 2008-04-30 2013-11-26 Kyoto University Metastin derivative and use thereof
CN107412725A (zh) * 2009-12-22 2017-12-01 武田药品工业株式会社 缓释制剂
US20130210742A1 (en) * 2010-06-25 2013-08-15 Takeda Pharmaceutical Company Limited Sustained-release formulation
JP6253146B2 (ja) * 2014-02-04 2017-12-27 国立大学法人山口大学 新規なペプチド誘導体及びこれを含有する医薬
WO2016099232A2 (ru) * 2014-10-20 2016-06-23 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтический состав лечебно-профилактического действия и способ его приготовления
TWI855377B (zh) 2016-09-30 2024-09-11 瑞士商麥歐文科學有限公司 治療女性不孕症之方法
WO2024206577A1 (en) * 2023-03-28 2024-10-03 Radionetics Oncology, Inc. Kisspeptin receptor (kiss1r) targeted therapeutics and uses thereof
WO2025217074A1 (en) 2024-04-08 2025-10-16 Radionetics Oncology, Inc. Kisspeptin receptor (kiss1r) targeted therapeutics and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003292696A1 (en) * 2002-12-26 2004-08-10 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
US6800611B2 (en) * 2003-01-06 2004-10-05 Takeda Chemical Industries, Ltd. Metastin derivatives and their use
BRPI0512397A (pt) * 2004-06-25 2008-03-04 Takeda Pharmaceutical composto,produto farmacêutico, métodos para suprimir a metástase de cáncer ou o crescimento do cáncer, para prevenir ou tratar uma doença ou condição, para controlar a função placentária, para melhorar a função gonadal, para induzir ou estimular a ovulação, para promover a secreção do hormÈnio gonadotrópico ou promover a secreção do hormÈnio sexual, para suprimir a secreção do hormÈnio gonadotrópico ou suprimir a secreção do hormÈnio sexual, para infra regular hormÈnio gonadrotópico ou hormÈnio sexual, e a proteìna ot7t175 humana, e para realçar a estabilidade no sangue, uso do composto, e, agente para suprimir a secreção do hormÈnio gonadotrópico ou um agente para suprimir a secreção do hormÈnio sexual
CN1972959A (zh) * 2004-06-25 2007-05-30 武田药品工业株式会社 转移素衍生物及其用途
AR058584A1 (es) * 2005-12-22 2008-02-13 Takeda Pharmaceutical Derivados de metastina y uso de los mismos

Similar Documents

Publication Publication Date Title
JP2012513982A5 (enExample)
CY1118862T1 (el) Νεα δικυκλικη ετεροκυκλικη ενωση
JP2009530392A5 (enExample)
JP2004534774A5 (enExample)
JP2011517453A5 (enExample)
RU2009115963A (ru) Производные оксадиазола, обладающие противовоспалительными и иммунодепрессантными свойствами
JP2008535903A5 (enExample)
JP2010505802A5 (enExample)
JP2011528658A5 (enExample)
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
EA201070872A1 (ru) Производные азабициклических карбоксамидов, их получение и их применение в терапии
RU2008123839A (ru) Соединение оксазола и фармацевтическая композиция
MX2010008101A (es) Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica.
WO2010005958A3 (en) 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
JP2013523896A5 (enExample)
JP2016505586A5 (enExample)
RU2014145819A (ru) Бициклическое соединение
JP2013500256A5 (enExample)
JP2011526917A5 (enExample)
JP2012505234A5 (enExample)
JP2013515037A5 (enExample)
JP2010155827A5 (enExample)
JP2009543795A5 (enExample)
JP2012528813A5 (enExample)